Event sponsored by:
AI Health
+DataScience (+DS)
Biomedical Engineering (BME)
Biostatistics and Bioinformatics
Duke Clinical and Translational Science Award (CTSA)
Electrical and Computer Engineering (ECE)
Pratt School of Engineering
Contact:
Duke AI HealthSpeaker:
Matthew Engelhard, MD, PhD; Assistant Professor of Biostatistics and Bioinformatics
Shelley Rusincovitch, MMCi; Managing Director, Duke AI Health
Shelley Rusincovitch, MMCi; Managing Director, Duke AI Health
The transformation in artificial intelligence (AI) and machine learning (ML) is impacting clinical medicine with potential for benefit but also harm. In this one-hour virtual seminar, we'll introduce AI and ML, highlight capabilities of current methods for images, text, and other big data in clinical settings, and discuss considerations in how to use these powerful methods responsibly. This session will be a high-level introduction accessible to people with no prior knowledge of AI and ML.
This is the first of a 3-part AI Health conversation series hosted by Shelley Rusincovitch:
- February 28: What are machine learning and artificial intelligence, and why do they matter in health? (with Matthew Engelhard)
- March 28: What are informatics and data science, and why do they matter in health? (with Ed Hammond and Warren Kibbe)
- April 25: What's important in the ethics and safety of artificial intelligence in health? (with David Carlson, Sarah Rispin Sedlak, and Jimmy Tcheng)